Confluence Pharmaceuticals
PrivateLast Round
Debt
Jun 21, 2022
Total Funding Raised
$2.1M
Company Overview
Confluence Pharmaceuticals is a biotechnology company developing novel therapeutic treatments for social and communication impairments caused by Fragile X Syndrome and Autism Spectrum Disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Confluence Pharmaceuticals Comparables
Compare Confluence Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 86% | |
| Kaerus Bioscience | 84% | |
| PaxMedica, Inc. | 83% | |
Confluence Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 21, 2022 | ||||
| VC Round | Jun 17, 2021 | ||||
| Debt | Dec 2, 2020 | ||||
| VC Round | Dec 20, 2018 | ||||
| Series A Extension | Sep 20, 2016 |
Confluence Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevate Ventures | Series A Extension |
| IU Ventures | Debt, VC Round |
| IU Philanthropic Venture Fund | Debt, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2016
$1.3M round with Elevate Ventures and 21st-century-research-and-technology-fund.
Confluence Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Confluence Pharmaceuticals's valuation, stock price, and market status.